Forward P/E of RadNet, Inc.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the imaging industry, including picture archiving communications systems; and provides teleradiology services for remote interpretation of images on behalf of radiology groups, hospitals, and imaging center customers. It owns and/or operates 305 outpatient imaging centers located in California, Maryland, Delaware, New Jersey, New York, and Rhode Island. The company was founded in 1981 and is headquartered in Los Angeles, California.
|Company||Industry||Est. EPS Q/Q|
|COHR Coherent, Inc.||NASDAQ > Capital Goods > Biotechnology: Laboratory Analytical Instruments||36.96%|
|SIVB SVB Financial Group||NASDAQ > Finance > Major Banks||37.04%|
|EQIX Equinix, Inc.||NASDAQ > Consumer Services > Real Estate Investment Trusts||37.21%|
|ADI Analog Devices, Inc.||NASDAQ > Technology > Semiconductors||37.23%|
|RRD R.R. Donnelley & Sons Company||NASDAQ > Miscellaneous > Publishing||37.25%|
|CIT CIT Group Inc (DEL)||NYSE > Finance > Finance: Consumer Services||37.29%|
|RDNT RadNet, Inc.||NASDAQ > Health Care > Medical Specialities||37.50%|
|CQH Cheniere Energy Partners LP Holdings, LLC||NYSEMKT > Public Utilities > Oil/Gas Transmission||2,100.00%|
|ACOR Acorda Therapeutics, Inc.||NASDAQ > Health Care > Biotechnology: Biological Products (No Diagnostic Substances)||2,120.00%|
|CG The Carlyle Group L.P.||NASDAQ > Finance > Investment Managers||2,600.00%|
|OZM Och-Ziff Capital Management Group LLC||NYSE > Finance > Investment Managers||2,800.00%|
|ALDW Alon USA Partners, LP||NYSE > Energy > Integrated oil Companies||4,600.00%|
|ANDV Andeavor||NYSE > Energy > Integrated oil Companies||4,866.67%|